FDA Drug Application (076521) for CARBIDOPA AND LEVODOPA by IMPAX LABS

Back to FDA Applications sponsored by IMPAX LABS

Application Number076521
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage25MG;100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCARBIDOPA AND LEVODOPA
Active IngredientCARBIDOPA; LEVODOPA

Active IngredientCount
List of drugs with Active Ingredient CARBIDOPA16
List of drugs with Active Ingredient LEVODOPA17


Back to FDA Applications sponsored by IMPAX LABS